Replies to post #29768 on Radient Pharmaceuticals Corporation fka RXPC

[GetSeriousOK]

Why would UNI merge into an OTC shell that has $20 million debt?

If UNI acquired RXPC stock, they could only have done so if the lenders dumped their shares. Which means the lender debt is still at LEAST $20 million.

UNI/Arima might merge into an OTC shell, but it won't be RXPC. The debt is prohibitive.

[livinginsv]

UNI would want a listed shell . . . a revoked, debt burdened, right to return NON-shell is not very attractive . . .

mac revoked the stock after he moved the assets to ADI . . . he left the debt and shareholders behind . . . it's been well over a year since revocation, and there is no excuse whatsoever to delay a market return . . . the only logical explanation is that retail owns the shares, and no execs have any reason to revive them . . . after a few years the penalties go up . . . the 2014 filing will trigger that clause, imo . . .

insurance paid the CA, without insurance rosen never would have filed . . .

as for UNI's efforts, kudos . . . it has ABSOLUTELY NOTHING to do with the former radient . . . royalties (if any) go to ADI . . .